about
Recent developments in human immunodeficiency virus-1 latency researchThe growth threshold conjecture: a theoretical framework for understanding T-cell toleranceGene expression profiles and protein–protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementiaThe heat shock protein 90 of Toxoplasma gondii is essential for invasion of host cells and tachyzoite growthCD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells.Alterations in the nuclear proteome of HIV-1 infected T-cells.Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1.Molecular determinants of the ratio of inert to infectious virus particles.Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores.HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression.Inhibition of Heat Shock Protein 90 Prevents HIV ReboundHeat Shock Factor 1 Mediates Latent HIV Reactivation.HIV-1 transcription and latency: an update.Natural Killer cell-dependent and non-dependent anti-viral activity of 2-Cys Peroxiredoxin against HIV.Heat shock protein 90 controls HIV-1 reactivation from latency.Adding new dimensions: towards an integrative understanding of HIV-1 spread.Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.Alteration of select gene expression patterns in individuals infected with HIV-1.Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition.ZNF10 inhibits HIV-1 LTR activity through interaction with NF-κB and Sp1 binding motifs.Quiescence promotes latent HIV infection and resistance to reactivation from latency with histone deacetylase inhibitors.Cellular fatty acid synthase is required for late stages of HIV-1 replication.Mycobacterial and HIV infections up-regulated human zinc finger protein 134, a novel positive regulator of HIV-1 LTR activity and viral propagation.SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells.Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity.An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors--potential therapeutics in cancer and neurodegeneration.Class 1-selective histone deacetylase inhibitors enhance HIV latency reversal while preserving the activity of HDAC isoforms necessary for maximal HIV gene expression.RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiationSerum deprivation/starvation leads to reactivation of HIV-1 in latently infected monocytes via activating ERK/JNK pathway
P2860
Q27013114-7C8A327D-4FA0-4564-AAF9-AA5F49F6CE65Q27335659-194082BA-52FD-4518-91C6-D49A81CEEB93Q30053318-DE26A2D7-E820-44D2-9418-BA7F54926749Q30544077-8C8142B1-BA4D-4171-9DF9-DF8FA6991A3AQ30557430-483C3279-F146-4094-B7E0-76092D1239B3Q34620114-B5DD6089-37C2-4231-A834-FA1B9FBE101BQ35126450-1FD1471C-9062-42CA-B30D-37228A23E910Q36494676-C882E54F-F4DB-48B4-9DE6-054BA8CA2204Q36584609-F59BED66-B13E-4926-B976-694D07A1133FQ36627905-FC01837B-A701-47F8-B0A0-98CFA91E1983Q36876244-C531EDE1-E34C-4881-80FB-17E5C26EFEC1Q36910965-48F5C15A-98DF-4CB4-8589-283262758A9BQ36976156-A871CB19-6709-4952-8186-F3A20763BD1AQ37305694-B9D71477-A7A7-4327-8E8B-974214CF554AQ37711958-3573C877-D6E4-4D05-9BA0-794962428B78Q38230087-8D9B66C7-426F-4FC6-A01F-DA80789842D2Q38758402-EDDBFA96-38BA-4E22-9150-41DC36CC45A7Q38832958-14E20A65-C579-45EB-A901-35D16233676DQ39259367-C4928333-5375-4B90-861B-4D6F791A23CBQ40473076-68D399CB-7D39-45DD-98B6-8DC734BE74C9Q41147495-6715046B-6DEE-4825-8B0A-4CF3DB073B42Q41918740-9FF1E763-46E3-4D7C-9FA6-25C497055071Q41927731-94D4303F-05B0-4C40-8533-047FFD674F7BQ42142791-D6ADCCB6-5CDD-4CCF-A751-628E5F044185Q42221145-6D185869-BC70-45A8-B540-7AA771FBD968Q42253119-429F7ABB-BD16-4A3F-A424-E071CFEE3D4BQ42875861-BE22CEBF-D923-4D8C-A037-44472BA8EF12Q47234362-C3F4D244-6EC8-47CF-AFD7-8EBEC9C677EBQ58700548-414E4C04-1A6D-4D79-85A9-D4B93591420DQ59128939-53DA3645-2455-4810-B67A-02773FBDE85C
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Hyperthermia stimulates HIV-1 replication
@ast
Hyperthermia stimulates HIV-1 replication
@en
Hyperthermia stimulates HIV-1 replication
@nl
type
label
Hyperthermia stimulates HIV-1 replication
@ast
Hyperthermia stimulates HIV-1 replication
@en
Hyperthermia stimulates HIV-1 replication
@nl
prefLabel
Hyperthermia stimulates HIV-1 replication
@ast
Hyperthermia stimulates HIV-1 replication
@en
Hyperthermia stimulates HIV-1 replication
@nl
P2093
P2860
P50
P1433
P1476
Hyperthermia stimulates HIV-1 replication
@en
P2093
Alessandro Marcello
Ferdinand Roesch
Françoise Porrot
Ian Anderson
Monsef Benkirane
Oussama Meziane
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002792
P577
2012-07-12T00:00:00Z